Cargando…
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
BACKGROUND: The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to update the guideline published in 2020. METHODS: The panelists searched MEDLIN...
Ejemplares similares
-
The 2021–2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice
por: Silva Júnior, Wellington S., et al.
Publicado: (2022) -
Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020
por: Vilela-Martin, José Fernando, et al.
Publicado: (2020) -
I Luso-Brazilian Positioning on Central Arterial
Pressure
por: Brandão, Andréa A., et al.
Publicado: (2017) -
Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
por: Melo, Miguel, et al.
Publicado: (2021) -
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus
por: Bertoluci, Marcello Casaccia, et al.
Publicado: (2020)